ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan · Delayed Price · Currency is TWD 18.90
+0.25 (1.34%)
Aug 7, 2026, 1:30 PM CST
ScinoPharm Taiwan Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,068 | 3,163 | 3,406 | 3,186 | 3,264 | 2,762 |
Revenue Growth | -3.97% | -7.13% | 6.91% | -2.39% | 18.16% | -10.40% |
Gross Profit Gross Profit Growth | 905.07 | 1,096 | 1,300 | 1,216 | 1,251 | 1,280 |
Operating Income Operating Income Growth | -68.51 | 108.91 | 321.04 | 314.49 | 405.5 | 288.62 |
Net Income Net Income Growth | 37.73 | 136.95 | 339.35 | 287.06 | 353.22 | 243.47 |
Earnings Per Share EPS Growth | 0.04 | 0.17 | 0.43 | 0.36 | 0.45 | 0.31 |
EPS Growth | -84.20% | -60.39% | 19.21% | -19.41% | 45.07% | -13.68% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Others Others Growth | 15.89 | 19.95 | 53.48 | 42.62 | 25.99 |
Scinopharm Taiwan, Ltd. Scinopharm Taiwan, Ltd. Growth | 3,109 | 3,139 | 3,007 | 3,069 | 2,643 |
Changshu Shenlong Changshu Shenlong Growth | 389.67 | 679.16 | 645.26 | 494.83 | 482.18 |
Inter Segment Inter Segment Growth | -351.04 | -431.89 | -519.61 | -342.84 | -388.66 |
Total Total Growth | 3,163 | 3,406 | 3,186 | 3,264 | 2,762 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3,499 | 3,110 | 4,166 | 3,942 | 4,295 | 4,081 |
Total Debt Total Debt Growth | 872.89 | 762.66 | 675.54 | 619.92 | 676.67 | 556.43 |
Net Cash (Debt) Net Cash Growth | 2,626 | 2,347 | 3,490 | 3,322 | 3,618 | 3,524 |
Net Cash Growth | 11.14% | -32.75% | 5.08% | -8.19% | 2.65% | 1.31% |
Net Cash Per Share Net Cash Per Share Growth | 3.03 | 2.96 | 4.40 | 4.19 | 4.56 | 4.45 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 805.83 | 595.91 | 750.91 | 231.13 | 773.79 | 509.82 |
Capital Expenditures CapEx Growth | -228.79 | -291.29 | -280.17 | -268.43 | -243.28 | -314.43 |
Free Cash Flow Free Cash Flow Growth | 577.04 | 304.62 | 470.74 | -37.3 | 530.51 | 195.4 |
Free Cash Flow Growth | 135.52% | -35.29% | - | - | 171.50% | -74.50% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 29.50% | 34.66% | 38.17% | 38.17% | 38.32% | 46.36% |
Operating Margin | -2.23% | 3.44% | 9.43% | 9.87% | 12.42% | 10.45% |
Pretax Margin | 0.29% | 4.66% | 12.13% | 10.95% | 13.42% | 10.94% |
Profit Margin | 1.23% | 4.33% | 9.96% | 9.01% | 10.82% | 8.81% |
FCF Margin | 18.81% | 9.63% | 13.82% | -1.17% | 16.25% | 7.07% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.290 | 0.290 | 0.350 | 0.300 | 0.360 | 0.480 |
Dividend Per Share Growth | -17.14% | -17.14% | 16.67% | -16.67% | -25.00% | -4.00% |
Dividend Yield | 1.55% | 1.76% | 1.64% | 1.19% | 1.50% | 2.10% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 396.12 | 96.71 | 51.38 | 72.72 | 56.98 | 80.06 |
Forward PE | - | 44.08 | 58.80 | 102.52 | 52.60 | 30.88 |
P/FCF Ratio | 25.90 | 43.48 | 37.04 | - | 37.93 | 99.76 |
PS Ratio | 4.87 | 4.19 | 5.12 | 6.55 | 6.17 | 7.06 |